Home › Companies › Summit Therapeutics Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Summit Therapeutics Inc.’s Form 8-K, filed 2026-06-12 (Item 5.07 on EDGAR). Page generated 02 October 2026.
Explore Summit Therapeutics Inc. in the interactive database Compare manager voting policies
These tallies are Summit Therapeutics Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Outcome |
|---|---|---|---|---|---|---|
| Elect Director: Robert W. Duggan | 636,409,964 | -- | -- | 10,761,538 | 30,576,341 | Majority: yes |
| Elect Director: Mahkam Zanganeh | 637,405,433 | -- | -- | 9,766,069 | 30,576,341 | Majority: yes |
| Elect Director: Manmeet Soni | 636,690,652 | -- | -- | 10,480,850 | 30,576,341 | Majority: yes |
| Elect Director: Kenneth A. Clark | 622,127,920 | -- | -- | 25,043,582 | 30,576,341 | Majority: yes |
| Elect Director: Robert Booth | 646,257,923 | -- | -- | 913,579 | 30,576,341 | Majority: yes |
| Elect Director: Alessandra Cesano | 646,263,718 | -- | -- | 907,784 | 30,576,341 | Majority: yes |
| Elect Director: Yu (Michelle) Xia | 636,028,876 | -- | -- | 11,142,626 | 30,576,341 | Majority: yes |
| Elect Director: Mostafa Ronaghi | 646,570,238 | -- | -- | 601,264 | 30,576,341 | Majority: yes |
| Elect Director: Jeff Huber | 646,659,701 | -- | -- | 511,801 | 30,576,341 | Majority: yes |
| Elect Director: Non-binding advisory vote to approve the compensation of named executive officers | 622,624,328 | 24,445,791 | 101,383 | -- | 30,576,341 | Majority: yes |
Source: Summit Therapeutics Inc., Form 8-K, filed with the SEC on 2026-06-12 — read the filing on EDGAR.
Each item below shows how the 225 asset managers that disclosed a Summit Therapeutics Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Summit Therapeutics Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 5 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Summit Therapeutics Inc.’s own tally for this item (“Elect Director: Non-binding advisory vote to approve the compensation of named executive officers”): 622,624,328 for, 24,445,791 against, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 776,017,474 outstanding shares: 80% for, 3% against (83% of the company cast a for/against vote).
The 223 asset managers below cast 20% of the shares they voted on this item FOR (8,307,813 for, 33,333,709 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 14,294,316 | 0 | 0 | Against |
| Fidelity | 7,658,644 | 1,931,414 | 0 | 0 | For |
| BlackRock | 11,995 | 2,719,528 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 2,079,711 | 0 | 0 | Against |
| State Street | 2,660 | 1,999,784 | 0 | 0 | Against |
| Charles Schwab | 2,525 | 1,878,747 | 0 | 0 | Against |
| PICTET ASSET MANAGEMENT SA | 0 | 1,488,970 | 0 | 0 | Against |
| Vanguard | 11,363 | 1,290,802 | 0 | 0 | Against |
| DE Shaw | 0 | 1,290,545 | 0 | 0 | Against |
| Aberdeen | 0 | 665,364 | 0 | 0 | Against |
| Candriam S.C.A. | 0 | 540,662 | 0 | 0 | Against |
| Wellington | 0 | 360,887 | 0 | 0 | Against |
| Northern Trust | 0 | 261,120 | 0 | 0 | Against |
| Allianz | 0 | 248,671 | 0 | 0 | Against |
| John Hancock | 0 | 195,493 | 0 | 0 | Against |
| GRIFFIN ASSET MANAGEMENT, INC. | 0 | 190,163 | 0 | 0 | Against |
| Woodline Partners LP | 182,023 | 0 | 0 | 0 | For |
| BANK OF AMERICA NA | 0 | 181,495 | 0 | 0 | Against |
| Invesco | 0 | 134,650 | 0 | 0 | Against |
| ProShares | 0 | 120,791 | 0 | 0 | Against |
| Tema ETF Trust | 120,314 | 0 | 0 | 0 | For |
| ADAR1 Capital Management, LLC | 0 | 88,900 | 0 | 0 | Against |
| WELLS FARGO CLEARING SERVICES, LLC | 87,947 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 82,527 | 0 | 0 | Against |
| Lincoln Financial | 0 | 77,100 | 0 | 0 | Against |
Showing the 25 largest of 223 asset managers. See all 223 in the interactive database.
Combines 2 wordings of this item as funds reported it.
12% fund support · no official result
The 48 asset managers below cast 12% of the shares they voted on this item FOR (1,801,287 for, 13,382,533 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 6,468,811 | 0 | 0 | Against |
| Fidelity | 7,725 | 3,957,999 | 0 | 0 | Against |
| State Street | 1,282,255 | 3,559 | 0 | 0 | For |
| Vanguard | 4,564 | 1,228,449 | 0 | 0 | Against |
| Charles Schwab | 1,262 | 937,252 | 0 | 0 | Against |
| BlackRock | 338,389 | 180,988 | 0 | 0 | For |
| John Hancock | 0 | 139,502 | 0 | 0 | Against |
| ProShares | 0 | 120,791 | 0 | 0 | Against |
| Tema ETF Trust | 120,314 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 77,100 | 0 | 0 | Against |
| Guggenheim | 0 | 47,079 | 0 | 0 | Against |
| Northern Lights Fund Trust IV | 31,953 | 0 | 0 | 0 | For |
| Equitable | 0 | 29,087 | 0 | 0 | Against |
| SEI | 0 | 23,900 | 0 | 0 | Against |
| TIAA | 0 | 23,195 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 22,605 | 0 | 0 | Against |
| New York Life | 0 | 20,009 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 19,140 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 11,400 | 0 | 0 | Against |
| Venerable Variable Insurance Trust | 0 | 9,346 | 0 | 0 | Against |
| Jackson National | 9,207 | 0 | 0 | 0 | For |
| Morgan Stanley | 0 | 9,048 | 0 | 0 | Against |
| Voya | 0 | 8,759 | 0 | 0 | Against |
| Goldman Sachs | 0 | 7,286 | 0 | 0 | Against |
| Pacific Life | 0 | 6,907 | 0 | 0 | Against |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Combines 3 wordings of this item as funds reported it.
100% fund support · no official result
The 46 asset managers below cast 100% of the shares they voted on this item FOR (15,180,881 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,468,811 | 0 | 0 | 0 | For |
| Fidelity | 3,965,724 | 0 | 0 | 0 | For |
| State Street | 1,285,814 | 0 | 0 | 0 | For |
| Vanguard | 1,233,013 | 0 | 0 | 0 | For |
| Charles Schwab | 938,514 | 0 | 0 | 0 | For |
| BlackRock | 519,377 | 0 | 0 | 0 | For |
| John Hancock | 139,502 | 0 | 0 | 0 | For |
| ProShares | 120,791 | 0 | 0 | 0 | For |
| Tema ETF Trust | 120,314 | 0 | 0 | 0 | For |
| Lincoln Financial | 77,100 | 0 | 0 | 0 | For |
| Guggenheim | 47,079 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 31,953 | 0 | 0 | 0 | For |
| Equitable | 29,087 | 0 | 0 | 0 | For |
| SEI | 23,900 | 0 | 0 | 0 | For |
| TIAA | 23,195 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,605 | 0 | 0 | 0 | For |
| New York Life | 20,009 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 19,140 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,400 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 9,346 | 0 | 0 | 0 | For |
| Jackson National | 9,207 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,048 | 0 | 0 | 0 | For |
| Voya | 8,759 | 0 | 0 | 0 | For |
| Goldman Sachs | 7,286 | 0 | 0 | 0 | For |
| Pacific Life | 6,907 | 0 | 0 | 0 | For |
Showing the 25 largest of 46 asset managers. See all 46 in the interactive database.
Combines 6 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Summit Therapeutics Inc.’s own tally for this item (“Elect Director: Alessandra Cesano”): 646,263,718 for, 907,784 withheld, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 776,017,474 outstanding shares: 83% for, 0.2% withheld (83% of the company cast a for/withheld vote).
The 45 asset managers below cast 100% of the shares they voted on this item FOR (15,132,325 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,468,811 | 0 | 0 | 0 | For |
| Fidelity | 3,965,724 | 0 | 0 | 0 | For |
| State Street | 1,285,340 | 0 | 474 | 0 | For |
| Vanguard | 1,229,134 | 0 | 3,878 | 0 | For |
| Charles Schwab | 938,514 | 0 | 0 | 0 | For |
| BlackRock | 519,377 | 0 | 0 | 0 | For |
| John Hancock | 139,502 | 0 | 0 | 0 | For |
| ProShares | 120,791 | 0 | 0 | 0 | For |
| Tema ETF Trust | 120,314 | 0 | 0 | 0 | For |
| Lincoln Financial | 77,100 | 0 | 0 | 0 | For |
| Guggenheim | 47,079 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 31,953 | 0 | 0 | 0 | For |
| Equitable | 29,087 | 0 | 0 | 0 | For |
| SEI | 23,900 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 23,195 | 0 | Abstain |
| Bridge Builder Trust | 22,605 | 0 | 0 | 0 | For |
| New York Life | 0 | 0 | 20,009 | 0 | Abstain |
| Direxion Shares ETF Trust | 19,140 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,400 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 9,346 | 0 | 0 | 0 | For |
| Jackson National | 9,207 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,048 | 0 | 0 | 0 | For |
| Voya | 8,759 | 0 | 0 | 0 | For |
| Goldman Sachs | 7,286 | 0 | 0 | 0 | For |
| Pacific Life | 6,907 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Combines 6 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Summit Therapeutics Inc.’s own tally for this item (“Elect Director: Jeff Huber”): 646,659,701 for, 511,801 withheld, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 776,017,474 outstanding shares: 83% for, 0.1% withheld (83% of the company cast a for/withheld vote).
The 45 asset managers below cast 100% of the shares they voted on this item FOR (15,155,520 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,468,811 | 0 | 0 | 0 | For |
| Fidelity | 3,965,724 | 0 | 0 | 0 | For |
| State Street | 1,285,340 | 0 | 474 | 0 | For |
| Vanguard | 1,229,134 | 0 | 3,878 | 0 | For |
| Charles Schwab | 938,514 | 0 | 0 | 0 | For |
| BlackRock | 519,377 | 0 | 0 | 0 | For |
| John Hancock | 139,502 | 0 | 0 | 0 | For |
| ProShares | 120,791 | 0 | 0 | 0 | For |
| Tema ETF Trust | 120,314 | 0 | 0 | 0 | For |
| Lincoln Financial | 77,100 | 0 | 0 | 0 | For |
| Guggenheim | 47,079 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 31,953 | 0 | 0 | 0 | For |
| Equitable | 29,087 | 0 | 0 | 0 | For |
| SEI | 23,900 | 0 | 0 | 0 | For |
| TIAA | 23,195 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,605 | 0 | 0 | 0 | For |
| New York Life | 0 | 0 | 20,009 | 0 | Abstain |
| Direxion Shares ETF Trust | 19,140 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,400 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 9,346 | 0 | 0 | 0 | For |
| Jackson National | 9,207 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,048 | 0 | 0 | 0 | For |
| Voya | 8,759 | 0 | 0 | 0 | For |
| Goldman Sachs | 7,286 | 0 | 0 | 0 | For |
| Pacific Life | 6,907 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Combines 6 wordings of this item as funds reported it.
96% Majority: yes · of votes cast
Summit Therapeutics Inc.’s own tally for this item (“Elect Director: Kenneth A. Clark”): 622,127,920 for, 25,043,582 withheld, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 776,017,474 outstanding shares: 80% for, 3% withheld (83% of the company cast a for/withheld vote).
The 45 asset managers below cast 100% of the shares they voted on this item FOR (3,632,957 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 6,468,811 | 0 | Abstain |
| Fidelity | 1,909,369 | 0 | 2,056,355 | 0 | Abstain |
| State Street | 2,612 | 0 | 1,283,202 | 0 | Abstain |
| Vanguard | 1,213,428 | 0 | 19,584 | 0 | For |
| Charles Schwab | 1,262 | 0 | 937,252 | 0 | Abstain |
| BlackRock | 338,389 | 0 | 180,988 | 0 | For |
| John Hancock | 0 | 0 | 139,502 | 0 | Abstain |
| ProShares | 0 | 0 | 120,791 | 0 | Abstain |
| Tema ETF Trust | 120,314 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 77,100 | 0 | Abstain |
| Guggenheim | 0 | 0 | 47,079 | 0 | Abstain |
| Northern Lights Fund Trust IV | 31,953 | 0 | 0 | 0 | For |
| Equitable | 0 | 0 | 29,087 | 0 | Abstain |
| SEI | 0 | 0 | 23,900 | 0 | Abstain |
| TIAA | 0 | 0 | 23,195 | 0 | Abstain |
| Bridge Builder Trust | 0 | 0 | 22,605 | 0 | Abstain |
| New York Life | 0 | 0 | 20,009 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 19,140 | 0 | Abstain |
| Columbia Threadneedle | 0 | 0 | 11,400 | 0 | Abstain |
| Venerable Variable Insurance Trust | 0 | 0 | 9,346 | 0 | Abstain |
| Jackson National | 9,207 | 0 | 0 | 0 | For |
| Morgan Stanley | 0 | 0 | 9,048 | 0 | Abstain |
| Voya | 0 | 0 | 8,759 | 0 | Abstain |
| Goldman Sachs | 0 | 0 | 7,286 | 0 | Abstain |
| Pacific Life | 0 | 0 | 6,907 | 0 | Abstain |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Summit Therapeutics Inc.’s own tally for this item (“Elect Director: Mahkam Zanganeh”): 637,405,433 for, 9,766,069 withheld, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 776,017,474 outstanding shares: 82% for, 1% withheld (83% of the company cast a for/withheld vote).
The 45 asset managers below cast 100% of the shares they voted on this item FOR (12,833,471 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,468,811 | 0 | 0 | 0 | For |
| Fidelity | 1,909,369 | 0 | 2,056,355 | 0 | Abstain |
| State Street | 1,284,291 | 0 | 1,523 | 0 | For |
| Vanguard | 1,217,311 | 0 | 15,702 | 0 | For |
| Charles Schwab | 938,514 | 0 | 0 | 0 | For |
| BlackRock | 519,377 | 0 | 0 | 0 | For |
| John Hancock | 125,304 | 0 | 14,198 | 0 | For |
| ProShares | 0 | 0 | 120,791 | 0 | Abstain |
| Tema ETF Trust | 120,314 | 0 | 0 | 0 | For |
| Lincoln Financial | 77,100 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 47,079 | 0 | Abstain |
| Northern Lights Fund Trust IV | 31,953 | 0 | 0 | 0 | For |
| Equitable | 29,087 | 0 | 0 | 0 | For |
| SEI | 23,900 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 23,195 | 0 | Abstain |
| Bridge Builder Trust | 22,605 | 0 | 0 | 0 | For |
| New York Life | 0 | 0 | 20,009 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 19,140 | 0 | Abstain |
| Columbia Threadneedle | 11,400 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 9,346 | 0 | 0 | 0 | For |
| Jackson National | 9,207 | 0 | 0 | 0 | For |
| Morgan Stanley | 0 | 0 | 9,048 | 0 | Abstain |
| Voya | 0 | 0 | 8,759 | 0 | Abstain |
| Goldman Sachs | 7,286 | 0 | 0 | 0 | For |
| Pacific Life | 6,907 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Summit Therapeutics Inc.’s own tally for this item (“Elect Director: Manmeet Soni”): 636,690,652 for, 10,480,850 withheld, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 776,017,474 outstanding shares: 82% for, 1% withheld (83% of the company cast a for/withheld vote).
The 45 asset managers below cast 100% of the shares they voted on this item FOR (12,789,872 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,468,811 | 0 | 0 | 0 | For |
| Fidelity | 1,909,369 | 0 | 2,056,355 | 0 | Abstain |
| State Street | 1,284,291 | 0 | 1,523 | 0 | For |
| Vanguard | 1,213,432 | 0 | 19,580 | 0 | For |
| Charles Schwab | 938,105 | 0 | 410 | 0 | For |
| BlackRock | 519,377 | 0 | 0 | 0 | For |
| John Hancock | 125,304 | 0 | 14,198 | 0 | For |
| ProShares | 0 | 0 | 120,791 | 0 | Abstain |
| Tema ETF Trust | 120,314 | 0 | 0 | 0 | For |
| Lincoln Financial | 77,100 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 47,079 | 0 | Abstain |
| Northern Lights Fund Trust IV | 31,953 | 0 | 0 | 0 | For |
| Equitable | 29,087 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 23,900 | 0 | Abstain |
| TIAA | 0 | 0 | 23,195 | 0 | Abstain |
| Bridge Builder Trust | 22,605 | 0 | 0 | 0 | For |
| New York Life | 0 | 0 | 20,009 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 19,140 | 0 | Abstain |
| Columbia Threadneedle | 11,400 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 9,346 | 0 | 0 | 0 | For |
| Jackson National | 0 | 0 | 9,207 | 0 | Abstain |
| Morgan Stanley | 0 | 0 | 9,048 | 0 | Abstain |
| Voya | 0 | 0 | 8,759 | 0 | Abstain |
| Goldman Sachs | 7,286 | 0 | 0 | 0 | For |
| Pacific Life | 6,907 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Combines 6 wordings of this item as funds reported it.
99.9% Majority: yes · of votes cast
Summit Therapeutics Inc.’s own tally for this item (“Elect Director: Mostafa Ronaghi”): 646,570,238 for, 601,264 withheld, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 776,017,474 outstanding shares: 83% for, 0.1% withheld (83% of the company cast a for/withheld vote).
The 45 asset managers below cast 100% of the shares they voted on this item FOR (15,139,175 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,468,811 | 0 | 0 | 0 | For |
| Fidelity | 3,965,724 | 0 | 0 | 0 | For |
| State Street | 1,285,340 | 0 | 474 | 0 | For |
| Vanguard | 1,233,013 | 0 | 0 | 0 | For |
| Charles Schwab | 938,514 | 0 | 0 | 0 | For |
| BlackRock | 519,377 | 0 | 0 | 0 | For |
| John Hancock | 139,502 | 0 | 0 | 0 | For |
| ProShares | 120,791 | 0 | 0 | 0 | For |
| Tema ETF Trust | 120,314 | 0 | 0 | 0 | For |
| Lincoln Financial | 77,100 | 0 | 0 | 0 | For |
| Guggenheim | 47,079 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 31,953 | 0 | 0 | 0 | For |
| Equitable | 16,347 | 0 | 12,740 | 0 | For |
| SEI | 23,900 | 0 | 0 | 0 | For |
| TIAA | 23,195 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 22,605 | 0 | 0 | 0 | For |
| New York Life | 0 | 0 | 20,009 | 0 | Abstain |
| Direxion Shares ETF Trust | 19,140 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,400 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 9,346 | 0 | 0 | 0 | For |
| Jackson National | 9,207 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,048 | 0 | 0 | 0 | For |
| Voya | 8,759 | 0 | 0 | 0 | For |
| Goldman Sachs | 0 | 0 | 7,286 | 0 | Abstain |
| Pacific Life | 6,907 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Combines 6 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Summit Therapeutics Inc.’s own tally for this item (“Elect Director: Robert Booth”): 646,257,923 for, 913,579 withheld, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 776,017,474 outstanding shares: 83% for, 0.2% withheld (83% of the company cast a for/withheld vote).
The 45 asset managers below cast 100% of the shares they voted on this item FOR (15,132,325 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,468,811 | 0 | 0 | 0 | For |
| Fidelity | 3,965,724 | 0 | 0 | 0 | For |
| State Street | 1,285,340 | 0 | 474 | 0 | For |
| Vanguard | 1,229,134 | 0 | 3,878 | 0 | For |
| Charles Schwab | 938,514 | 0 | 0 | 0 | For |
| BlackRock | 519,377 | 0 | 0 | 0 | For |
| John Hancock | 139,502 | 0 | 0 | 0 | For |
| ProShares | 120,791 | 0 | 0 | 0 | For |
| Tema ETF Trust | 120,314 | 0 | 0 | 0 | For |
| Lincoln Financial | 77,100 | 0 | 0 | 0 | For |
| Guggenheim | 47,079 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 31,953 | 0 | 0 | 0 | For |
| Equitable | 29,087 | 0 | 0 | 0 | For |
| SEI | 23,900 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 23,195 | 0 | Abstain |
| Bridge Builder Trust | 22,605 | 0 | 0 | 0 | For |
| New York Life | 0 | 0 | 20,009 | 0 | Abstain |
| Direxion Shares ETF Trust | 19,140 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 11,400 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 9,346 | 0 | 0 | 0 | For |
| Jackson National | 9,207 | 0 | 0 | 0 | For |
| Morgan Stanley | 9,048 | 0 | 0 | 0 | For |
| Voya | 8,759 | 0 | 0 | 0 | For |
| Goldman Sachs | 7,286 | 0 | 0 | 0 | For |
| Pacific Life | 6,907 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Summit Therapeutics Inc.’s own tally for this item (“Elect Director: Robert W. Duggan”): 636,409,964 for, 10,761,538 withheld, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 776,017,474 outstanding shares: 82% for, 1% withheld (83% of the company cast a for/withheld vote).
The 45 asset managers below cast 100% of the shares they voted on this item FOR (12,833,471 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,468,811 | 0 | 0 | 0 | For |
| Fidelity | 1,909,369 | 0 | 2,056,355 | 0 | Abstain |
| State Street | 1,284,291 | 0 | 1,523 | 0 | For |
| Vanguard | 1,217,311 | 0 | 15,702 | 0 | For |
| Charles Schwab | 938,514 | 0 | 0 | 0 | For |
| BlackRock | 519,377 | 0 | 0 | 0 | For |
| John Hancock | 125,304 | 0 | 14,198 | 0 | For |
| ProShares | 0 | 0 | 120,791 | 0 | Abstain |
| Tema ETF Trust | 120,314 | 0 | 0 | 0 | For |
| Lincoln Financial | 77,100 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 47,079 | 0 | Abstain |
| Northern Lights Fund Trust IV | 31,953 | 0 | 0 | 0 | For |
| Equitable | 29,087 | 0 | 0 | 0 | For |
| SEI | 23,900 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 23,195 | 0 | Abstain |
| Bridge Builder Trust | 22,605 | 0 | 0 | 0 | For |
| New York Life | 0 | 0 | 20,009 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 19,140 | 0 | Abstain |
| Columbia Threadneedle | 11,400 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 9,346 | 0 | 0 | 0 | For |
| Jackson National | 9,207 | 0 | 0 | 0 | For |
| Morgan Stanley | 0 | 0 | 9,048 | 0 | Abstain |
| Voya | 0 | 0 | 8,759 | 0 | Abstain |
| Goldman Sachs | 7,286 | 0 | 0 | 0 | For |
| Pacific Life | 6,907 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Combines 6 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Summit Therapeutics Inc.’s own tally for this item (“Elect Director: Yu (Michelle) Xia”): 636,028,876 for, 11,142,626 withheld, per its Form 8-K filed 2026-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 776,017,474 outstanding shares: 82% for, 1% withheld (83% of the company cast a for/withheld vote).
The 45 asset managers below cast 100% of the shares they voted on this item FOR (12,832,913 for, 0 against).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 6,468,811 | 0 | 0 | 0 | For |
| Fidelity | 1,909,369 | 0 | 2,056,355 | 0 | Abstain |
| State Street | 1,284,291 | 0 | 1,523 | 0 | For |
| Vanguard | 1,217,310 | 0 | 15,703 | 0 | For |
| Charles Schwab | 938,514 | 0 | 0 | 0 | For |
| BlackRock | 519,377 | 0 | 0 | 0 | For |
| John Hancock | 125,304 | 0 | 14,198 | 0 | For |
| ProShares | 0 | 0 | 120,791 | 0 | Abstain |
| Tema ETF Trust | 120,314 | 0 | 0 | 0 | For |
| Lincoln Financial | 77,100 | 0 | 0 | 0 | For |
| Guggenheim | 0 | 0 | 47,079 | 0 | Abstain |
| Northern Lights Fund Trust IV | 31,953 | 0 | 0 | 0 | For |
| Equitable | 29,087 | 0 | 0 | 0 | For |
| SEI | 23,900 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 23,195 | 0 | Abstain |
| Bridge Builder Trust | 22,605 | 0 | 0 | 0 | For |
| New York Life | 0 | 0 | 20,009 | 0 | Abstain |
| Direxion Shares ETF Trust | 0 | 0 | 19,140 | 0 | Abstain |
| Columbia Threadneedle | 11,400 | 0 | 0 | 0 | For |
| Venerable Variable Insurance Trust | 9,346 | 0 | 0 | 0 | For |
| Jackson National | 9,207 | 0 | 0 | 0 | For |
| Morgan Stanley | 0 | 0 | 9,048 | 0 | Abstain |
| Voya | 0 | 0 | 8,759 | 0 | Abstain |
| Goldman Sachs | 7,286 | 0 | 0 | 0 | For |
| Pacific Life | 6,907 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Ranked by the number of Summit Therapeutics Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 776,017,474 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 1.84% |
| 2 | Fidelity | 1.24% |
| 3 | BlackRock | 0.35% |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | 0.27% |
| 5 | State Street | 0.26% |
| 6 | Charles Schwab | 0.24% |
| 7 | PICTET ASSET MANAGEMENT SA | 0.19% |
| 8 | Vanguard | 0.17% |
| 9 | DE Shaw | 0.17% |
| 10 | Aberdeen | 0.09% |
Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).
| Holder | % outstanding | Disclosure |
|---|---|---|
| Robert W. Duggan | 73.46% | DEF14A |
| Mahkam Zanganeh | 4.64% | DEF14A |
| Yu (Michelle) Xia | 4.13% | DEF14A |
| Vanguard Group | 1.44% | 13F |
| FMR (Fidelity) | 1.40% | 13F |
| BlackRock | 1.24% | 13F |
| T. Rowe Price | 1.07% | 13F |
| State Street | 0.91% | 13F |
| Geode Capital | 0.43% | 13F |
| Manmeet Soni | 0.40% | DEF14A |
Percentages above are of 776,017,474 shares outstanding, as reported by Summit Therapeutics Inc. on its Form 10-Q dated 2026-03-31 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Summit Therapeutics Inc.’s 10-Q dated 2026-03-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.
At Summit Therapeutics Inc.'s shareholder meeting held 2026-06-10, in the 2025-2026 proxy season, 225 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,507 separate fund positions. Their filings are grouped here into 12 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Approval, by a non-binding advisory vote, of the compensation of our named executive officers. — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Summit Therapeutics Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-06-12.
Summit Therapeutics Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).